Fig. 1 · Structure
Documents & Downloads
β-CCB
Benzodiazepine Receptor Ligand
β-CCB is a potent ligand for the benzodiazepine receptor, demonstrating inhibitory activity on the binding of [3H]flunitrazepam and ethyl (3-[3H]carboline-3-carboxylate with a Ki value of 3-4 nM. This compound exhibits proconvulsant and anxiogenic effects, making it valuable for research in neuropharmacology and anxiety disorder models. Its selective binding properties contribute to investigations into the mechanisms of benzodiazepine action and potential therapeutic targets.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Ligand / Binder |
| CAS Number | 84454-35-3 |
| Applications | Benzodiazepine Receptor Ligand |
| Formula | C16H16N2O2 |
| Molecular Weight | 268.31 |
| SMILES | O=C(C1=CC2=C(C=N1)NC3=C2C=CC=C3)OCCCC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.